Tag: Loanstar Technologies

Lynch Regenerative Medicine has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.

Lynch Regenerative Medicine has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Lynch Regenerative Medicine is raising up to $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Samuel Lynch played…

Read More Read More

Loanstar Technologies has filed a notice of an exempt offering of securities to raise $28,665,276.00 in New Equity Investment.

Loanstar Technologies has filed a notice of an exempt offering of securities to raise $28,665,276.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Loanstar Technologies is raising up to $28,665,276.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Andrew Turner played a…

Read More Read More